↓ Skip to main content

Cochrane Database of Systematic Reviews

Aripiprazole for autism spectrum disorders (ASD)

Overview of attention for article published in this source, May 2012
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
11 tweeters
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
106 Mendeley
citeulike
1 CiteULike
Title
Aripiprazole for autism spectrum disorders (ASD)
Published by
John Wiley & Sons, Ltd, May 2012
DOI 10.1002/14651858.cd009043.pub2
Pubmed ID
Authors

Ching, Heidi, Pringsheim, Tamara

Abstract

Autism spectrum disorders (ASD) include Autistic Disorder, Asperger's Disorder and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). Irritability related to ASD has been treated with antipsychotics. Aripiprazole, a third generation atypical antipsychotic, is a relatively new drug that has a unique mechanism of action different from other antipsychotics.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 <1%
Spain 1 <1%
France 1 <1%
Unknown 103 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 19%
Student > Bachelor 14 13%
Student > Master 11 10%
Other 10 9%
Student > Doctoral Student 9 8%
Other 27 25%
Unknown 15 14%
Readers by discipline Count As %
Medicine and Dentistry 38 36%
Psychology 13 12%
Agricultural and Biological Sciences 6 6%
Biochemistry, Genetics and Molecular Biology 5 5%
Neuroscience 5 5%
Other 19 18%
Unknown 20 19%